Aptabio Therapeutics Inc.
Aptabio Therapeutics develops platform drugs targeting oxidative stress, cancer-associated fibroblasts, and aptamer conjugates to treat diabetes complications, vascular & neurodegenerative diseases, and hard‑to‑treat cancers. Based in Yongin‑si, South Korea.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- HQ: Yongin-si
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.